Obesity Trial, Recruiting NCT07654439 Sponsor: Selcuk University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07654439
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a Body Mass Index (BMI) of 25 or higher, which is generally considered overweight or obese.
  • People who are able to walk around on their own without assistance.
  • People aged between 18 and 65 years old.
  • People who are willing to take part voluntarily and sign a consent form agreeing to participate.

Who may not be able to join:

  • People who are currently taking medication specifically for weight loss or obesity.
  • People who are pregnant.
  • People who have a condition called Latent Autoimmune Diabetes in Adults (LADA), a specific type of diabetes (confirm with trial site if unsure whether this applies).
  • People who have chronic kidney disease.
  • People who have an active or serious infection.
  • People who have liver failure.
  • People who have recently experienced a major heart or cardiovascular event, such as a heart attack (confirm with trial site on what timeframe counts as "recent").
  • People who have unstable chest pain (unstable angina).
  • People with a serious level of heart failure, classified as NYHA Class III or IV, meaning heart problems that significantly limit physical activity or cause symptoms at rest.
  • People with breathing failure, irregular heart rhythms, cancer, or nervous system or bone and muscle conditions that could make it unsafe to perform the study tests.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: İsmail ÖZSOY, Assoc. Prof. Dr., Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye

Phone: 5558175133

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Selcuk University
Registry
ClinicalTrials.gov
Start date
10 June 2026
Est. completion
30 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Timed Up and Go Test - Mixed Reality (TUG-MR); 4-Meter Walk Test - Mixed Reality (4MW-MR); Five-Repetition Sit-to-Stand Test - Mixed Reality (5xSTS-MR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov